Search Login Register
Fluorescein
(Funduscein)
Summary
Description:
A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium, such as the aqueous humor, and is used therapeutically as a diagnostic aid in corneal injuries and corneal trauma. It has been approved by FDA for use in externally applied drugs and cosmetics. (From Merck Index, 12th ed; American Medical Association Drug Evaluations; 1995, p2275)
Also Known As:
Funduscein; Alcon Brand of Fluorescein Sodium; Allergan Brand of Fluorescein Sodium; C.I. 45350; Cahill May Roberts Brand of Fluorescein Sodium Show All >>
Networked: 5213
relevant articles (144 outcomes,
541 trials/studies)
for this Drug
Key Diseases for which Fluorescein is
Relevant
-
Macular Edema
:
23 outcomes 24 studies in 317 results
-
Choroidal Neovascularization
:
11 outcomes 29 studies in 253 results
-
Neoplasms (Cancer)
:
7 outcomes 35 studies in 379 results
-
Inflammation
:
7 outcomes 8 studies in 103 results
-
Hemorrhage
:
6 outcomes 8 studies in 140 results
Show All >>
Drugs Related to Fluorescein
-
Retinaldehyde (Retinal)
-
isothiocyanic acid
-
Rose Bengal
-
Indocyanine Green (Cardio-Green)
-
bevacizumab
-
Fluorescein-5-isothiocyanate (FITC)
-
1-phenyl-3,3-dimethyltriazene (PDT)
-
Dextrans (Dextran)
-
verteporfin (Visudyne)
-
DNA (Deoxyribonucleic Acid)
Show All >>
Therapies Related to Fluorescein
-
Light Coagulation
-
Lasers (Laser)
-
Photochemotherapy (Photodynamic Therapy)
-
Aftercare (After-Treatment)
-
Intravitreal Injections
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.